Avalo Therapeutics (AVTX) Intangibles (2017 - 2021)

Avalo Therapeutics (AVTX) has 5 years of Intangibles data on file, last reported at $38000.0 in Q4 2021.

• Quarterly Intangibles fell 97.6% year-over-year to $38000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $38000.0 (down 97.6% YoY) and the FY2021 annual result came in at $38000.0, down 97.6% from the prior year.
• Intangibles fell to $38000.0 in Q4 2021, from $304000.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $33.1 million in Q1 2018 to a low of $38000.0 in Q4 2021.
• A 5-year average of $10.9 million and a median of $2.3 million in 2020 frame the typical range for Intangibles.
• The widest YoY moves for Intangibles: up 29.0% in 2021, down 97.6% in 2021.
• Tracing AVTX's Intangibles over 5 years: stood at $17.7 million in 2017, then tumbled by 78.68% to $3.8 million in 2018, then sank by 35.57% to $2.4 million in 2019, then sank by 34.67% to $1.6 million in 2020, then sank by 97.6% to $38000.0 in 2021.
• The last three Intangibles figures came in at $38000.0 (Q4 2021), $304000.0 (Q3 2021), and $732000.0 (Q2 2021), per Business Quant data.